Hua Han Health Industry Holdings Limited manufactures pharmaceutical products. The Company develops and sells gynecological anti inflammatory products, golden peptides, polar peptides, and other products. Hua Han Health Industry Holdings also provides hospital management services.
In Q3 2016, Emerson Analytics and Zhongkui Research published reports pointing out that the company has inflated revenue, fabricated sales and overstated value of property acquired from related parties. Trading was suspended on 27 Sep 2016.
Zhongkui Research: Report on Hua Han Health, 22 Sep 2016
Emerson Analytics: Hua Han – Bad for Your Financial Health, 10 Aug 2016